Invites Biocore Co., Ltd. (XKON:216400)

Market Cap	28.53B
Revenue (ttm)	16.96B
Net Income (ttm)	667.63M
Shares Out	7.71M
EPS (ttm)	163.00
PE Ratio	22.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23
Average Volume	1,127
Open	3,780.00
Previous Close	3,795.00
Day's Range	3,500.00 - 3,780.00
52-Week Range	2,655.00 - 7,790.00
Beta	-0.01
RSI	62.57
Earnings Date	n/a

About Invites Biocore

Invites Biocore Co., Ltd. provides bioanalytical and central lab services in South Korea and internationally. It offers bioanalytical testing service during biological equivalence tests, clinical trials, toxicokinetics, nonclinical trials, vivo dynamic analysis, comparative dissolution test, and biomarker analysis; provides project strategic planning, medical translation, clinical research, quality assurance, monitoring, and data management for clinical services; and offers services, such as pharmaceutical quality control testing, emergency tes...

• Industry: Testing Laboratories
• Founded: 2001
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 216400

Financial Performance

In 2014, Invites Biocore's revenue was 16.96 billion, an increase of 29.35% compared to the previous year's 13.11 billion. Earnings were 667.63 million, a decrease of -17.76%.